Shanghai No. 1 Pharmaceutical Company Limited operates within the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shanghai No. 1 Pharmaceutical Company Limited with three other
drug stores in Asia:
Apex Healthcare Bhd
sales of 526.86 million Malaysian Ringgits [US$118.05 million]
of which 94%
was Wholesale and Distribution),
Medical Ikkou Co Ltd
(26.39 billion Japanese Yen [US$234.32 million]
of which 81%
was Pharmacies), and
Sapporo Clinical Laboratory Inc.
based in Japan
(17.17 billion Japanese Yen [US$152.44 million]
of which 62%
was Dispensing Pharmacy Business).
During the year ended December of 2015, sales at
Shanghai No. 1 Pharmaceutical Company Limited were 1.49 billion Chinese Renmimbi (US$217.21 million).
increase of 5.4%
versus 2014, when the company's sales were 1.41 billion Chinese Renmimbi.
Sales of Wholesale Trade saw an increase
9.9% in 2015, from
697.75 million Chinese Renmimbi to 766.93 million Chinese Renmimbi.
Not all segments of Shanghai No. 1 Pharmaceutical Company Limited experienced an increase in sales in 2015:
sales of Other Operation fell 0.6% to 51.76 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).